Bruker Corp (BRKRP) stock
BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$442.19−17.24 (-3.75%)
Close on Nov 12, 2026Market cap $9.36BP/E –Yield –
Bruker ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bruker's ebitda for the twelve months ending Sep 30, 2026 was $158.70M, down 43.1% year over year. For fiscal 2025 it was $288.50M, down 34.0% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $551.80M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $288.50M | -34.0% |
| FY2024 | Dec 31, 2024 | $436.90M | -20.8% |
| FY2023 | Dec 31, 2023 | $551.80M | +5.8% |
| FY2022 | Dec 31, 2022 | $521.50M | +3.8% |
| FY2021 | Dec 31, 2021 | $502.40M | +52.8% |
| FY2020 | Dec 31, 2020 | $328.70M | -12.7% |
| FY2019 | Dec 31, 2019 | $376.50M | +15.0% |
| FY2018 | Dec 31, 2018 | $327.30M | +15.5% |
| FY2017 | Dec 31, 2017 | $283.40M | +20.0% |
| FY2016 | Dec 31, 2016 | $236.10M | +18.6% |
| FY2015 | Dec 31, 2015 | $199.00M | +20.5% |
| FY2014 | Dec 31, 2014 | $165.10M | -21.2% |
| FY2013 | Dec 31, 2013 | $209.50M | -2.6% |
| FY2012 | Dec 31, 2012 | $215.10M | +3.2% |
| FY2011 | Dec 31, 2011 | $208.50M | +8.7% |
| FY2010 | Dec 31, 2010 | $191.80M | +15.3% |
| FY2009 | Dec 31, 2009 | $166.40M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$36.90M | -1046.2% |
| Q2 FY2026 | Jun 30, 2026 | -$7.30M | -110.7% |
| Q1 FY2026 | Mar 31, 2026 | $68.50M | -16.7% |
| Q4 FY2025 | Dec 31, 2025 | $134.40M | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.90M | -96.7% |
| Q2 FY2025 | Jun 30, 2025 | $68.00M | -27.0% |
| Q1 FY2025 | Mar 31, 2025 | $82.20M | -17.4% |
| Q4 FY2024 | Dec 31, 2024 | $125.00M | -11.2% |
| Q3 FY2024 | Sep 30, 2024 | $119.10M | -21.2% |
| Q2 FY2024 | Jun 30, 2024 | $93.20M | -16.9% |
| Q1 FY2024 | Mar 31, 2024 | $99.50M | -32.7% |
| Q4 FY2023 | Dec 31, 2023 | $140.80M | -9.5% |
| Q3 FY2023 | Sep 30, 2023 | $151.10M | -0.8% |
| Q2 FY2023 | Jun 30, 2023 | $112.10M | +17.4% |
| Q1 FY2023 | Mar 31, 2023 | $147.80M | +25.0% |
| Q4 FY2022 | Dec 31, 2022 | $155.50M | +4.8% |
| Q3 FY2022 | Sep 30, 2022 | $152.30M | +12.5% |
| Q2 FY2022 | Jun 30, 2022 | $95.50M | -10.9% |
| Q1 FY2022 | Mar 31, 2022 | $118.20M | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $148.40M | +10.3% |
| Q3 FY2021 | Sep 30, 2021 | $135.40M | +33.1% |
| Q2 FY2021 | Jun 30, 2021 | $107.20M | +87.7% |
| Q1 FY2021 | Mar 31, 2021 | $111.40M | +214.7% |
| Q4 FY2020 | Dec 31, 2020 | $134.50M | -1.1% |
| Q3 FY2020 | Sep 30, 2020 | $101.70M | -4.7% |
| Q2 FY2020 | Jun 30, 2020 | $57.10M | -21.7% |
| Q1 FY2020 | Mar 31, 2020 | $35.40M | -41.9% |
| Q4 FY2019 | Dec 31, 2019 | $136.00M | +10.6% |
| Q3 FY2019 | Sep 30, 2019 | $106.70M | +25.5% |
| Q2 FY2019 | Jun 30, 2019 | $72.90M | +11.5% |
| Q1 FY2019 | Mar 31, 2019 | $60.90M | +13.0% |
| Q4 FY2018 | Dec 31, 2018 | $123.00M | +10.8% |
| Q3 FY2018 | Sep 30, 2018 | $85.00M | +24.3% |
| Q2 FY2018 | Jun 30, 2018 | $65.40M | +27.5% |
| Q1 FY2018 | Mar 31, 2018 | $53.90M | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | $111.00M | +22.2% |
| Q3 FY2017 | Sep 30, 2017 | $68.40M | – |
| Q2 FY2017 | Jun 30, 2017 | $51.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $90.80M | – |
See a number that looks wrong?